A Phase 2 interventional study of N-Acetylcysteine in acute ischemic stroke
Completed Phase 2 NCT04918719
Study Description
Evaluating the effectiveness of intravenous N-Acetylcysteine in improving outcomes for acute ischemic stroke patients
Study Details
- Registry ID:
- NCT04918719
- Conditions:
- Acute Ischemic Stroke
- Phase:
- Phase 2
- Target Enrollment:
- 4 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Harbor-UCLA Medical Center
Torrance, California, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.